A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy

about

A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy

Item

http://www.wikidata.org/entity/Q57491566

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@en

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@nl

type

Item

label

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@en

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@nl

prefLabel

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@en

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@nl

P1476

A New Approach for Loading Ant ...... me Mimetics for Cancer Therapy

@en

P2093

Arunnehru Gopal

http://www.w3.org/2001/XMLSchema#string

Byeong-Cheol Ahn

http://www.w3.org/2001/XMLSchema#string

Ho Won Lee

http://www.w3.org/2001/XMLSchema#string

Jaetae Lee

http://www.w3.org/2001/XMLSchema#string

Ji Min Oh

http://www.w3.org/2001/XMLSchema#string

Liya Zhu

http://www.w3.org/2001/XMLSchema#string

Prakash Gangadaran

http://www.w3.org/2001/XMLSchema#string

Ramya Lakshmi Rajendran

http://www.w3.org/2001/XMLSchema#string

Sang-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Se Hwan Baek

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions

Neurological adverse effects caused by cytotoxic and targeted therapies.

Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.

Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy

Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.

Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Paclitaxel (taxol)

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.

P304

1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01116

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319428

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6168623

http://www.w3.org/2001/XMLSchema#string